Figure 1.
Biomarker types used for clinical management of DMD(*) and potential markers under development.
Abbreviations: CK, creatine kinase; DMD, Duchenne muscular dystrophy.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.